Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019
{{output}}
Objectives: Primary: Analyze the Adverse Events (AEs) reported to the Food and Drug Administration (FDA) after use of mifepristone as an abortifacient. Secondary: Analyze maternal intent after ongoing pregnancy and investigate he... ...
